These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33729677)

  • 1. The difference between effect modification and covariate confounding.
    Marlin N; Allotey J
    BJOG; 2021 Sep; 128(10):1574. PubMed ID: 33729677
    [No Abstract]   [Full Text] [Related]  

  • 2. Confounding obscures our view, effect modification is part of reality.
    Knottnerus JA; Tugwell P
    J Clin Epidemiol; 2019 Oct; 114():v-vi. PubMed ID: 31570139
    [No Abstract]   [Full Text] [Related]  

  • 3. The control of confounding by intermediate variables.
    Robins J
    Stat Med; 1989 Jun; 8(6):679-701. PubMed ID: 2749074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconfounding confounding part 3: controlling for confounding in statistical analyses.
    Richardson AM; Joshy G
    Med J Aust; 2020 Sep; 213(5):209-212.e1. PubMed ID: 33448418
    [No Abstract]   [Full Text] [Related]  

  • 5. Redressing the balance: Covariate adjustment in randomised trials.
    Kahan BC; Morris TP
    BJOG; 2021 Sep; 128(10):1573. PubMed ID: 34124821
    [No Abstract]   [Full Text] [Related]  

  • 6. Sources of confounding in life course epidemiology.
    Santos S; Zugna D; Pizzi C; Richiardi L
    J Dev Orig Health Dis; 2019 Jun; 10(3):299-305. PubMed ID: 30111382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecological bias, confounding, and effect modification.
    Greenland S; Morgenstern H
    Int J Epidemiol; 1989 Mar; 18(1):269-74. PubMed ID: 2656561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of unmeasured confounding on the MR Steiger approach.
    Lutz SM; Voorhies K; Wu AC; Hokanson J; Vansteelandt S; Lange C
    Genet Epidemiol; 2022 Mar; 46(2):139-141. PubMed ID: 35170805
    [No Abstract]   [Full Text] [Related]  

  • 9. Applying the E Value to Assess the Robustness of Epidemiologic Fields of Inquiry to Unmeasured Confounding.
    Trinquart L; Erlinger AL; Petersen JM; Fox M; Galea S
    Am J Epidemiol; 2019 Jun; 188(6):1174-1180. PubMed ID: 30874728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Charlson Index Is Insufficient to Control for Comorbidities in a National Trauma Registry.
    Renson A; Bjurlin MA
    J Surg Res; 2019 Apr; 236():319-325. PubMed ID: 30694772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmeasured Confounding in Observational Studies of Management of Cerebellar Intracranial Hemorrhage-Reply.
    Kuramatsu JB; Sheth KN; Huttner HB
    JAMA; 2020 Feb; 323(7):666. PubMed ID: 32068814
    [No Abstract]   [Full Text] [Related]  

  • 12. Theorems, proofs, examples, and rules in the practice of epidemiology.
    Vanderweele TJ; Ogburnb EL
    Epidemiology; 2012 May; 23(3):443-5. PubMed ID: 22475829
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining, Quantifying, and Interpreting "Noncollapsibility" in Epidemiologic Studies of Measures of "Effect".
    Whitcomb BW; Naimi AI
    Am J Epidemiol; 2021 May; 190(5):697-700. PubMed ID: 33305812
    [No Abstract]   [Full Text] [Related]  

  • 14. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control.
    Wood ME; Lapane KL; van Gelder MMHJ; Rai D; Nordeng HME
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):140-147. PubMed ID: 29044735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence of confounding on the target population: a modification of causal graphs to account for co-action.
    Flanders WD; Johnson CY; Howards PP; Greenland S
    Ann Epidemiol; 2011 Sep; 21(9):698-705. PubMed ID: 21737305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariate balance for no confounding in the sufficient-cause model.
    Suzuki E; Tsuda T; Yamamoto E
    Ann Epidemiol; 2018 Jan; 28(1):48-53.e2. PubMed ID: 29241736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of low to moderate relative risks in environmental epidemiologic studies.
    Acquavella JF; Friedlander BR; Ireland BK
    Annu Rev Public Health; 1994; 15():179-201. PubMed ID: 8054080
    [No Abstract]   [Full Text] [Related]  

  • 18. Causal Diagrams: Pitfalls and Tips.
    Suzuki E; Shinozaki T; Yamamoto E
    J Epidemiol; 2020 Apr; 30(4):153-162. PubMed ID: 32009103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of directed acyclic graphs in identifying and controlling confounding bias].
    Liu HX; Wang HB; Wang N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Apr; 41(4):585-588. PubMed ID: 32344486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the Editor: Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies (SMMR, Vol. 27, Issue 6, 2018).
    Gran JM; Aalen OO
    Stat Methods Med Res; 2019 Jan; 28(1):321-322. PubMed ID: 30392452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.